The slightly lower fraction in cohort #1 might be explainable by a selection bias, as only intermediate to high-risk prostate adenocarcinoma have been included for primary staging with PSMA-PET imaging [3]. This evidence concerns the gene FOLH1 and prostate adenocarcinoma.